Skip to main content
Clinical Trials/DRKS00025816
DRKS00025816
Recruiting
未知

Evaluation of Smartphone-based Monitoring as a Biomarker of Deep-brain Stimulation Response in Parkinson’s disease - SmartDBS

niversitätsklinikum Düsseldorf0 sites60 target enrollmentJuly 9, 2021
ConditionsG20.90

Overview

Phase
未知
Intervention
Not specified
Conditions
G20.90
Sponsor
niversitätsklinikum Düsseldorf
Enrollment
60
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 9, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Düsseldorf

Eligibility Criteria

Inclusion Criteria

  • Levodopa treatment for at least 3 months prior to the first measurement
  • \- Ability to understand the study procedure
  • \- Planned THS surgery for the treatment of idiopathic Parkinson's syndrome
  • \- Eligible for MRI measurement
  • \- Informed consent, signed and dated by the subject or, in the case of motor impairment, by an independent witness

Exclusion Criteria

  • \- Presence of a legally authorized representative
  • \- Presence of conditions other than idiopathic Parkinson's disease that may worsen motor or cognitive abilities, such as corticobasal syndrome, multisystem atrophy, dementia, severe arthritis, drug/alcohol abuse, Alzheimer's disease, stroke, or similar conditions
  • \- Inability to remain seated in the MEG scanner without involuntary movements producing artifacts
  • \- Inability to undergo MRI scanning, e.g., metal implants or tattoos containing metal
  • \- Past or present participation in pharmacologic clinical trials related to idiopathic Parkinson's syndrome
  • \- Claustrophobia
  • \- Unable to tolerate levodopa medication withdrawal for at least 12 hours (including dysphagia, tendency to fall)
  • \- Inability to walk

Outcomes

Primary Outcomes

Not specified

Similar Trials